A randomized study including 563 participants at the University of Pittsburgh concluded that:
“In injured patients at risk for hemorrhagic shock, the prehospital administration of thawed plasma was safe and resulted in lower 30-day mortality and a lower median prothrombin time ratio than standard-care resuscitation.” The study was funded by the U.S. Army Medical Research and Materiel Command; PAMPer ClinicalTrials.gov number, NCT01818427.
